These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2382644)
21. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141 [TBL] [Abstract][Full Text] [Related]
22. Iron overload and mobilization in long-term hemodialysis patients. Hakim RM; Stivelman JC; Schulman G; Fosburg M; Wolfe L; Imber MJ; Lazarus JM Am J Kidney Dis; 1987 Oct; 10(4):293-9. PubMed ID: 3661550 [TBL] [Abstract][Full Text] [Related]
23. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Fishbane S; Frei GL; Maesaka J Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266 [TBL] [Abstract][Full Text] [Related]
24. Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin. Hou CC; Wu SC; Wu SC; Yang WC; Huang TP; Ng YY Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):456-62. PubMed ID: 9745161 [TBL] [Abstract][Full Text] [Related]
25. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Tarng DC; Huang TP; Chen TW; Yang WC Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294 [TBL] [Abstract][Full Text] [Related]
26. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC; Hung SC; Tarng DC Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [TBL] [Abstract][Full Text] [Related]
27. Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients. Agroyannis B; Koutsicos D; Tzanatou-Exarchou H; Varsou-Papadimitriou E; Kapetanaki A; Yatzidis H Int J Artif Organs; 1991 Jul; 14(7):403-6. PubMed ID: 1889892 [TBL] [Abstract][Full Text] [Related]
28. Low dose desferrioxamine can improve erythropoiesis in iron-overload hemodialysis patients without side effects. Lee CT; Liao SC; Hsu KT; Lam KK; Chen JB Ren Fail; 1999 Nov; 21(6):665-73. PubMed ID: 10586429 [TBL] [Abstract][Full Text] [Related]
29. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients. Park L; Uhthoff T; Tierney M; Nadler S Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194 [TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients. Nissenson AR; Berns JS; Sakiewicz P; Ghaddar S; Moore GM; Schleicher RB; Seligman PA Am J Kidney Dis; 2003 Aug; 42(2):325-30. PubMed ID: 12900815 [TBL] [Abstract][Full Text] [Related]
31. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients. Raja R; Bloom E; Johnson R Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918 [TBL] [Abstract][Full Text] [Related]
32. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507 [TBL] [Abstract][Full Text] [Related]
33. National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients. Owen WF; Szczech L; Johnson C; Frankenfield D Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S5-S11. PubMed ID: 10516369 [TBL] [Abstract][Full Text] [Related]
34. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]
35. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487 [TBL] [Abstract][Full Text] [Related]
36. Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients. Chang CH; Chang CC; Chiang SS Clin Nephrol; 2002 Feb; 57(2):136-41. PubMed ID: 11863124 [TBL] [Abstract][Full Text] [Related]
37. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population. Raja R; Bloom E; Goldstein M; Johnson R ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603 [TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin treatment of anemia in renal transplant patients. Lezaic V; Djukanovic L; Pavlovic-Kentera V Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243 [TBL] [Abstract][Full Text] [Related]
39. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis]. Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178 [TBL] [Abstract][Full Text] [Related]
40. Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin. Romero R; Novoa D; Otero S; Alonso MC; Alonso R; Arcocha V; Arza D; Lens XM; Sanchez-Guisande D Nephron; 1993; 63(2):164-7. PubMed ID: 8450906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]